---
figid: PMC7406421__gr2_lrg
figlink: pmc/articles/PMC7406421/figure/fig2/
number: F2
caption: 'The Mechanism of human CoVID-19 infection: 1: infected animals can infect
  Humans followed by human-to-human transmission through aerial droplets and contact.
  2: life cycle begins with S protein binds to the cellular receptor ACE2. After receptor
  binding, S protein facilitates viral envelope fusion with the cell membrane through
  the endosomal pathway. Then CoVID-19 releases RNA into the host cell. Viral genomic
  RNA is translated into viral replicase polyproteins, which are then cleaved into
  small viral proteases. The RNA polymerase generates a series of sub genomic mRNAs
  and finally translated into all viral proteins. Viral genome RNA and proteins are
  subsequently assembled into virions in the endoplasmic reticulum, then to Golgi
  and transported via vesicles and released out of the cell. 3: CoVID-19 infection
  results in activation of epithelial cells, macrophages and dendritic cells. Antigens
  will be presented to the antigen presentation cells (APC), which triggers body''s
  anti-viral immunity and uncontrolled systemic inflammatory response resulting from
  the release of large amounts of pro-inflammatory cytokines (IFN-α, IFN-γ, IL-1β,
  IL-6, IL-12, IL-18, IL-33, TNF-α, TGFβ, etc.) and chemokines (CCL2, CCL3, CCL5,
  CXCL8, CXCL9, CXCL10, etc.) by immune effector cells. 4: The cytokine storm will
  trigger a violent attack of immune system to the body, results in leaky blood vessels,
  cellular oedema and collapsed alveolar function. 5: Increased amount of IL6 and
  IL-1β results in activation of prostaglandins which results in increased body temperature.
  5: System inflammation leads to decreased blood volume and increased hat ? function.
  Finally, it results in multiple organ failure, and may lead to death in severe cases.'
pmcid: PMC7406421
papertitle: 'Antiviral properties of placental growth factors: A novel therapeutic
  approach for COVID-19 treatment.'
reftext: Meghnad G. Joshi, et al. Placenta. 2020 Sep 15;99:117-130.
pmc_ranked_result_index: '102211'
pathway_score: 0.7749215
filename: gr2_lrg.jpg
figtitle: 'Mechanism of human CoVID-19 infection: 1: infected animals can infect Humans
  followed by human-to-human transmission through aerial droplets and contact'
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7406421__gr2_lrg.html
  '@type': Dataset
  description: 'The Mechanism of human CoVID-19 infection: 1: infected animals can
    infect Humans followed by human-to-human transmission through aerial droplets
    and contact. 2: life cycle begins with S protein binds to the cellular receptor
    ACE2. After receptor binding, S protein facilitates viral envelope fusion with
    the cell membrane through the endosomal pathway. Then CoVID-19 releases RNA into
    the host cell. Viral genomic RNA is translated into viral replicase polyproteins,
    which are then cleaved into small viral proteases. The RNA polymerase generates
    a series of sub genomic mRNAs and finally translated into all viral proteins.
    Viral genome RNA and proteins are subsequently assembled into virions in the endoplasmic
    reticulum, then to Golgi and transported via vesicles and released out of the
    cell. 3: CoVID-19 infection results in activation of epithelial cells, macrophages
    and dendritic cells. Antigens will be presented to the antigen presentation cells
    (APC), which triggers body''s anti-viral immunity and uncontrolled systemic inflammatory
    response resulting from the release of large amounts of pro-inflammatory cytokines
    (IFN-α, IFN-γ, IL-1β, IL-6, IL-12, IL-18, IL-33, TNF-α, TGFβ, etc.) and chemokines
    (CCL2, CCL3, CCL5, CXCL8, CXCL9, CXCL10, etc.) by immune effector cells. 4: The
    cytokine storm will trigger a violent attack of immune system to the body, results
    in leaky blood vessels, cellular oedema and collapsed alveolar function. 5: Increased
    amount of IL6 and IL-1β results in activation of prostaglandins which results
    in increased body temperature. 5: System inflammation leads to decreased blood
    volume and increased hat ? function. Finally, it results in multiple organ failure,
    and may lead to death in severe cases.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACE2
  - CRP
  - SLC17A5
  - IL18
  - IL6
  - CCL2
  - CXCL10
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA7
  - IFNA8
  - IFNA17
  - IFNA6
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - TNF
  - TGFB1
  - TGFB2
  - TGFB3
  - IL33
  - IL12A
  - IL12B
  - CXCL8
  - CCL5
  - CXCL9
  - GAST
  - Creatinine
  - Nitrogen
  - Hypotensive
  - Edema
  - Hypoxia
genes:
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: AST/ALT/CRP
  symbol: CRP
  source: hgnc_symbol
  hgnc_symbol: CRP
  entrez: '1401'
- word: AST/ALT/CRP
  symbol: AST
  source: hgnc_alias_symbol
  hgnc_symbol: SLC17A5
  entrez: '26503'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL6,
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: CCL2,
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: CXCL10
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: (IFN-a,
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: TNF-a,
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: IL-33,
  symbol: IL33
  source: hgnc_symbol
  hgnc_symbol: IL33
  entrez: '90865'
- word: IL-12,
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12,
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-18,IL-6,IL-12,IL-18,IL-33,TNF-a,TGFB,
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-18,IL6,
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-18,IL6,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: (CCL2,
  symbol: CCL2
  source: hgnc_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: CXCL8,
  symbol: CXCL8
  source: hgnc_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: CCL5,
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: chemokines(CCL2,CL3,CCL5,CXCL8,
  symbol: CXCL8
  source: hgnc_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: chemokines(CCL2,CL3,CCL5,CXCL8,
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: CXCL9,
  symbol: CXCL9
  source: hgnc_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: CXCL10,
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: CXCL9,CXCL10,etc.)
  symbol: CXCL9
  source: hgnc_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: CXCL9,CXCL10,etc.)
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: Gas
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
chemicals:
- word: Creatinine
  source: MESH
  identifier: D003404
- word: Nitrogen
  source: MESH
  identifier: D009584
diseases:
- word: Hypotensive
  source: MESH
  identifier: D007022
- word: Edema
  source: MESH
  identifier: D004487
- word: Hypoxia
  source: MESH
  identifier: D000860
figid_alias: PMC7406421__F2
redirect_from: /figures/PMC7406421__F2
figtype: Figure
---
